Vasopressin Anti-Idiotypic Antibody Staining in the Rat Brain: Colocalization with [35S][pGlu4, Cyt6]AVP(4?9)Binding Sites
- 1 October 1993
- journal article
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 5 (5) , 523-531
- https://doi.org/10.1111/j.1365-2826.1993.tb00517.x
Abstract
Vasopressin and its fragment peptides such as [pGlu4, Cyt6]AVP(4-9) (AVP(4-9) represent putative neuromodulators within central nervous homeostatic, memory and behavioural circuits. To localize their central receptor systems, the previously characterized monoclonal anti-idiotypic antibody mAb 237 was employed in immunocytological investigations of rat brain tissue sections. This antibody was raised to the monoclonal idiotypic anti-AVP antibody mAb 113 which preferentially binds to the acyclic C-terminal portion of the AVP molecule and is therefore also capable of binding the naturally occurring AVP(4-9) fragment. Immunoreactive magnocellular neurones were detected in the AVP-synthesizing supraoptic but not paraventricular nuclei. Dense staining was observed within circumventricular organs lacking a blood-brain barrier (BBB). These structures include the subfornical organ, the organum vasculosum laminae terminalis, the internal layer of the median eminence, the body of the pineal gland, the choroid plexus and the area postrema, where immunoreactivity was found on capillaries, neurones and fibres. Further staining was found in the nucleus of the solitari tract and the arcuate nucleus, endowed with a leaky BBB. Distinct cell patches in the ependymal lining of the third ventricle as well as dendritic processes of juxtaependymal neurones were labelled by the anti-idiotypic antibody mAb 237. The observed staining pattern did not parallel that obtained in autoradiographic studies performed using either radiolabelled AVP or a V1-receptor antagonist, but that found with the [35S]-labelled AVP(4-9) fragment. Using [35S]-labelled AVP(4-9) fragment, specific high density binding sites could be localized autoradiographically in structures within and outside the BBB, in complete agreement with the anti-idiotypic immunoreactivity. Since the anti-idiotypic methodology is based on transfer of complementary structures, and the epitope recognized by the corresponding idiotypic antibody resembles the sequence of AVP(4-9), the anti-idiotypic antibodies might recognize the AVP(4-9) receptor with high affinity.Keywords
This publication has 42 references indexed in Scilit:
- Generation of anti-idiotypic monoclonal antibodies recognizing vasopressin receptors in cultured cells and kidney sectionsExperimental Cell Research, 1992
- Proteolytic conversion of oxytocin by brain synaptic membranes: Role of aminopeptidases and endopeptidasesPeptides, 1991
- Anti-idiotypes used in immunohistochemistryJournal of Molecular Histology, 1990
- Monoclonal antibodies against different epitopes of peptide hormonesEuropean Journal of Biochemistry, 1990
- In vivo conversion of vasopressin after microinjection into limbic brain areas of ratsPeptides, 1989
- Vasopressin reduces release from vasopressin-neurons and oxytocin-neurons by acting on V2-like receptorsBrain Research, 1989
- Circadian variations of vasopressin level and vasopressin-converting aminopeptidase activity in the rat pineal glandPeptides, 1988
- Enhanced antigen-antibody binding affinity mediated by an anti-idiotypic antibodyBiochemistry, 1987
- Vasopressin metabolite, AVP4–9, binding sites in brain: Distribution distinct from that of parent peptideLife Sciences, 1986
- Characterization of two putative smooth muscle cell lines from rat thoracic aortaExperimental Cell Research, 1976